First Light Asset Management, LLC Abcam PLC Transaction History

First Light Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$12.62 - $24.47 $4.18 Million - $8.1 Million	331,034 Added 87.18%	710,745 $17.4 Million
Q1 2023 May 15, 2023	BUY	$12.98 - $17.1 $999 - $1,316	77 Added 0.02%	379,711 $5.11 Million
Q4 2022 Feb 14, 2023	SELL	$13.92 - $17.0 $54,608 - $66,691	-3,923 Reduced 1.02%	379,634 $5.91 Million
Q3 2022 Nov 14, 2022	BUY	$13.36 - $16.75 $2.17 Million - $2.73 Million	162,719 Added 73.68%	383,557 $5.75 Million
Q2 2022 Aug 12, 2022	SELL	$12.69 - $19.25 $32,334 - $49,049	-2,548 Reduced 1.14%	220,838 $3.19 Million
Q1 2022 May 13, 2022	BUY	$15.5 - $23.89 $63,565 - $97,972	4,101 Added 1.87%	223,386 $4.09 Million
Q4 2021 Feb 14, 2022	BUY	$20.04 - $23.84 $4.39 Million - $5.23 Million	219,285 New	219,285 $5.16 Million

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on First Light Asset Management, LLC with notifications on news.